Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Henry

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
Child: Care, Health and Development|September 30, 2025
Play Together? Unveiling Facilitators and Barriers to Inclusive Outdoor Play for Dutch Children With and Without Disabilities: A Qualitative StudyR Q Beekhuizen, E A M Bolster, J W Gorter, et al.
Climacteric : the Journal of the International Menopause Society|May 11, 2010
Modeling hot flushes and quality of life in breast cancer survivorsK L Rand, J L Otte, D Flockhart, et al.
British Journal of Cancer|July 8, 2010
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control studyN L Henry, D Pchejetski, R A'Hern, et al.
British Journal of Cancer|December 3, 2009
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyN L Henry, A Nguyen, F Azzouz, et al.
Child: Care, Health and Development|December 4, 2025
Can You See Us Play? Observing Inclusive Outdoor Play Behaviour Among Children With and Without Disabilities: A Mixed Methods StudyR Q Beekhuizen, M A T Bloemen, E A M Bolster, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
The Pharmacogenomics Journal|August 24, 2016
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerD L Hertz, K M Kidwell, N J Seewald, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
Child: Care, Health and Development|September 30, 2025
Play Together? Unveiling Facilitators and Barriers to Inclusive Outdoor Play for Dutch Children With and Without Disabilities: A Qualitative StudyR Q Beekhuizen, E A M Bolster, J W Gorter, et al.
Climacteric : the Journal of the International Menopause Society|May 11, 2010
Modeling hot flushes and quality of life in breast cancer survivorsK L Rand, J L Otte, D Flockhart, et al.
British Journal of Cancer|July 8, 2010
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control studyN L Henry, D Pchejetski, R A'Hern, et al.
British Journal of Cancer|December 3, 2009
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyN L Henry, A Nguyen, F Azzouz, et al.
Child: Care, Health and Development|December 4, 2025
Can You See Us Play? Observing Inclusive Outdoor Play Behaviour Among Children With and Without Disabilities: A Mixed Methods StudyR Q Beekhuizen, M A T Bloemen, E A M Bolster, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
The Pharmacogenomics Journal|August 24, 2016
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerD L Hertz, K M Kidwell, N J Seewald, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.
Pageof 4